COVID-19 Therapy: Could a Copper Derivative of Chlorophyll a Be Used to Treat Lymphopenia Associated With Severe Symptoms of SARS-CoV-2 Infection?

Frontiers in Medicine

Andrew W. Taylor-Robinson¹  Nicole F. Clark² 

[1] Infectious Diseases Research Group, School of Health, Medical and Applied Sciences, Central Queensland University, Brisbane, QLD, Australia;College of Health and Human Sciences, Charles Darwin University, Casuarina, NT, Australia;Institute for Applied Ecology, University of Canberra, Bruce, ACT, Australia;Centre for Marine Bioproducts Development, College of Medicine and Public Health, Flinders University, Bedford Park, SA, Australia;

关键词: chlorophyll;    therapy;    lymphopenia;    SARS-CoV-2;    COVID-19;    coronavirus;    sodium copper chlorophyllin;   

DOI  :  10.3389/fmed.2021.620175

来源: Frontiers

【 授权许可】

CC BY